GO:0061789 dense core granule priming: Vesicle Priming Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061789 dense core granule priming is the biological process that converts unprimed dense core granules (DCVs) into fusion-competent, primed vesicles after docking.
• Priming requires the coordinated action of Munc13-2, CAPS1, synaptotagmin-7, and calcium signaling to render DCVs ready for exocytosis.
• Tomosyn acts as a calcium-dependent inhibitor of large dense-core vesicle priming, providing a negative regulatory brake.
• CAPS1 is a dedicated priming factor that also regulates DCV acidification through interaction with rabconnectin3β/WDR7.
• Dense core granule priming is essential for regulated secretion of hormones, neuropeptides, and catecholamines from neuroendocrine and neuronal cells.
• Dysregulation of DCV priming contributes to neurological and endocrine disorders, making it a target for CRISPR-based functional studies.
Description
Dense core granule priming (GO:0061789) is a late step in the regulated secretory pathway that converts docked but fusion-incompetent dense core vesicles (DCVs) into a pool of primed vesicles capable of fusing with the plasma membrane upon calcium influx. This process is essential for the timed release of neuropeptides, hormones, and catecholamines from neurons and neuroendocrine cells. Unlike synaptic vesicle priming, DCV priming occurs on a slower timescale and involves distinct molecular players such as CAPS1, Munc13-2, and synaptotagmin-7. Understanding the molecular mechanisms of DCV priming is critical for deciphering how cells control the strength and duration of regulated secretion. Research into GO:0061789 has been accelerated by reconstitution assays, live-cell imaging, and genetic perturbation studies. These approaches have revealed that priming is not a single event but a multi-step process requiring ATP, calcium, and specific protein-protein interactions. The priming factor CAPS1, for example, is recruited to DCVs and promotes both acidification and fusion competence. Synaptotagmin-7 acts as a calcium sensor that positions DCVs at the plasma membrane and enables Munc13-2-dependent priming. Tomosyn, by contrast, inhibits priming in a calcium-dependent manner, highlighting the existence of negative regulatory mechanisms. For researchers, GO:0061789 represents a convergence point for studies of neurosecretion, endocrine function, and vesicle trafficking. Dysregulation of DCV priming has been linked to impaired hormone release and neurological disease, making it a compelling target for CRISPR-based knockout, knock-in, and point-mutation models. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of dense core granule priming, its key genes, regulatory mechanisms, and experimental methods.
dense core granule priming At A Glance
| GO ID | GO:0061789 |
|---|---|
| GO term | dense core granule priming |
| Ontology | biological_process |
| Synonym | dense core vesicle priming; large dense-core vesicle priming; LDCV priming |
| Definition | A process that converts unprimed dense core granules (DCVs) to a pool of primed vesicles that are capable of fusing with the plasma membrane (fusion-competent) and thereby releasing their contents. Priming typically occurs after docking. |
| Major function | Renders docked DCVs fusion-competent for regulated exocytosis of hormones, neuropeptides, and catecholamines |
| Key regulators | CAPS1, Munc13-2, synaptotagmin-7, tomosyn, rabconnectin3β/WDR7 |
| Cellular context | Neuroendocrine cells, neurons, and endocrine cells |
| Calcium dependence | Priming is calcium-dependent and involves calcium sensors such as synaptotagmin-7 |
What Is GO:0061789?
According to the Gene Ontology, dense core granule priming (GO:0061789) is defined as the process that converts unprimed dense core granules (DCVs) to a pool of primed vesicles that are capable of fusing with the plasma membrane (fusion-competent) and thereby releasing their contents. Priming typically occurs after docking. In simpler terms, it is the molecular maturation step that makes a docked dense core vesicle ready to release its cargo when calcium signals arrive.
Why Is dense core granule priming Important in Cell Biology?
Dense core granule priming is a rate-limiting step in regulated secretion, determining how many vesicles are available for release and thus controlling the amplitude and kinetics of hormone and neuropeptide secretion. Its importance extends from basic neurobiology to endocrine physiology and disease, as defects in priming can lead to impaired secretion and neurological dysfunction.
• Controls the size of the readily releasable pool of dense core vesicles in neuroendocrine cells.
• Regulates secretion of catecholamines, insulin, and neuropeptides.
• Involved in synaptic plasticity and neuronal communication.
• Dysregulation linked to neurological and psychiatric disorders.
• Target for understanding endocrine disorders such as diabetes.
• Provides a model for studying calcium-dependent membrane fusion.
• Key step for drug discovery targeting regulated secretion.
• Essential for immune cell granule release and inflammation.
• Relevant to cancer cell vesicle secretion and tumor microenvironment.
• Enables reconstitution studies of exocytosis machinery.
What Happens During dense core granule priming?
Docking and Initial Priming Steps
In simple terms: First, the vesicle attaches to the cell membrane and gets prepared for release.
Dense core granules are first docked at the plasma membrane, after which priming converts them into fusion-competent vesicles. This step requires the recruitment of priming factors such as CAPS1 and Munc13-2 to the vesicle membrane. Synaptotagmin-7 places DCVs at the cell membrane to promote Munc13-2- and Ca2+-dependent priming.
Role of CAPS1 in Priming and Acidification
In simple terms: CAPS1 is a protein that helps the vesicle both mature and become ready to fuse.
CAPS1 is a dedicated priming factor that regulates dense-core vesicle acidification by interacting with rabconnectin3β/WDR7 in neuroendocrine cells. CAPS1 RNA editing further promotes DCV exocytosis, indicating that post-transcriptional modifications fine-tune priming. Loss of CAPS1 impairs priming and reduces the pool of fusion-competent vesicles.
Calcium-Dependent Regulation by Synaptotagmin-7 and Munc13-2
In simple terms: Calcium acts as a trigger that helps the vesicle reach the final primed state.
Synaptotagmin-7 acts as a calcium sensor that positions DCVs at the plasma membrane and enables Munc13-2-dependent priming. This calcium dependence ensures that priming is tightly coupled to cellular signals that demand secretion. Reconstitution studies have shown that calcium-mediated exocytosis of DCVs requires specific lipid and protein components.
Negative Regulation by Tomosyn
In simple terms: Tomosyn acts as a brake that can slow down or stop the priming process.
Tomosyn inhibits priming of large dense-core vesicles in a calcium-dependent manner. This negative regulation prevents excessive vesicle priming and maintains a balance between releasable and reserve pools. The interplay between positive regulators like CAPS1 and negative regulators like tomosyn determines the overall priming state.
Fusion Competence and Cargo Release
In simple terms: Once primed, the vesicle is ready to fuse and release its contents when calcium levels rise.
After priming, DCVs become fusion-competent and can release their contents upon calcium influx. This final step is mediated by the SNARE complex and calcium sensors, leading to membrane fusion and cargo release. The primed pool is functionally defined by its ability to undergo rapid exocytosis.
Key Genes Involved in GO:0061789 dense core granule priming
The following genes and proteins are central to dense core granule priming, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CAPS1 (CADPS) | Priming factor; regulates DCV acidification via rabconnectin3β/WDR7 | Knockout models show impaired DCV priming and secretion |
| Munc13-2 (UNC13B) | Essential priming factor for DCV fusion competence | Required for synaptotagmin-7-dependent priming |
| Synaptotagmin-7 (SYT7) | Calcium sensor that positions DCVs and promotes priming | Knockdown reduces primed pool and secretion |
| Tomosyn (STXBP5) | Negative regulator of LDCV priming in a calcium-dependent manner | Overexpression inhibits priming; KO increases secretion |
| Rabconnectin3β (WDR7) | Interacts with CAPS1 to regulate DCV acidification | Modulates priming efficiency |
| Rab3A | Small GTPase involved in vesicle docking and priming | Regulates vesicle pool dynamics |
| Munc18-1 (STXBP1) | SNARE-binding protein required for priming | Mutations linked to neurological disorders |
| Syntaxin-1A (STX1A) | Plasma membrane SNARE involved in fusion | Target for knockout studies of exocytosis |
| SNAP-25 | SNARE protein essential for vesicle fusion | Cleaved by botulinum toxins, affecting priming |
| VAMP2 (SYB2) | Vesicle SNARE required for fusion | Knockout impairs DCV exocytosis |
| Ca2+ channels (e.g., Cav2.1) | Provide calcium for priming and fusion | Modulate priming efficiency |
| PKA | Phosphorylates priming machinery | Regulates CAPS1 activity |
| PKC | Enhances priming via Munc13 phosphorylation | Pharmacological modulation of secretion |
| Calmodulin | Calcium sensor involved in priming | Required for reconstituted exocytosis |
| NSF | ATPase that recycles SNARE complexes | Essential for sustained priming |
| α-SNAP | Cofactor for NSF in SNARE recycling | Regulates vesicle pool replenishment |
| Complexin | Clamps and activates SNARE-mediated fusion | Modulates primed vesicle release |
| Rabphilin-3A | Effector of Rab3A in priming | Regulates vesicle recruitment |
How Is dense core granule priming Regulated?
Dense core granule priming is regulated by calcium signaling, protein phosphorylation, and small GTPases. Calcium influx triggers synaptotagmin-7 and Munc13-2 to promote priming. Tomosyn provides calcium-dependent inhibition, preventing excessive priming. CAPS1 activity is modulated by RNA editing and interaction with rabconnectin3β/WDR7. Protein kinase A and C can phosphorylate components of the priming machinery, altering priming efficiency. Rab3A and its effector rabphilin-3A contribute to vesicle recruitment and priming.
dense core granule priming and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CAPS1 (CADPS) | Endocrine disorders, impaired hormone secretion | Knockout neuroendocrine cell lines (e.g., PC12) |
| Munc13-2 (UNC13B) | Neurological disorders, synaptic dysfunction | Point-mutation knock-in mice |
| Synaptotagmin-7 (SYT7) | Psychiatric disorders, impaired neurosecretion | Overexpression and knockout models |
| Tomosyn (STXBP5) | Neurological and metabolic disorders | Knockout and overexpression cell models |
| Rabconnectin3β (WDR7) | Endocrine dysfunction | Knock-in tagged models for interaction studies |
Neurological and Psychiatric Disorders
Dysregulation of dense core granule priming has been implicated in neurological and psychiatric disorders due to its role in neuropeptide and neurotransmitter release. Mutations in priming factors such as Munc13-2 and synaptotagmin-7 can impair synaptic transmission and contribute to disease phenotypes. CAPS1 RNA editing changes have been linked to altered DCV exocytosis, suggesting a role in neurodevelopmental conditions.
Endocrine Disorders
Impaired DCV priming in endocrine cells can lead to insufficient hormone secretion, contributing to conditions such as diabetes and growth disorders. CAPS1 and rabconnectin3β/WDR7 are critical for insulin granule priming in pancreatic beta cells. Understanding these mechanisms may reveal therapeutic targets for enhancing hormone release.
Cancer and Immune Regulation
Extracellular vesicles and co-isolated endogenous retroviruses from murine cancer cells differentially affect dendritic cells, highlighting a role for regulated secretion in tumor immunology. Dense core granule priming machinery may influence the release of immune-modulatory vesicles from cancer cells. Targeting priming pathways could modulate anti-tumor immune responses.
Infectious Disease and Host Cell Death
Toxoplasma gondii effectors protect against interferon gamma-driven human host cell death, illustrating how pathogens manipulate host secretory pathways. Although direct links to DCV priming are not established, the overlap in vesicle trafficking pathways suggests potential crosstalk. Further research is needed to explore this connection.
From dense core granule priming-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CAPS1 loss impair DCV priming? | CAPS1 knockout neuroendocrine cells |
| How does synaptotagmin-7 mutation affect calcium-dependent priming? | Point-mutation knock-in of SYT7 |
| Can tomosyn overexpression inhibit LDCV priming? | Tomosyn overexpression in PC12 cells |
| What is the role of Munc13-2 in priming? | Munc13-2 knockout and rescue models |
| Does CAPS1 RNA editing regulate DCV exocytosis? | Knock-in of edited CAPS1 variants |
| How does rabconnectin3β interact with CAPS1? | Tagged knock-in for co-immunoprecipitation |
How to Study the dense core granule priming Process
| Method | What It Measures | Typical Application |
|---|---|---|
| TIRF microscopy | DCV docking and priming events | Live-cell imaging of priming dynamics |
| Reconstitution assay | Calcium-dependent fusion of DCVs | In vitro dissection of priming machinery |
| Amperometry | Catecholamine release from single vesicles | Quantifying primed pool size |
| Patch-clamp capacitance | Membrane capacitance changes | Measuring readily releasable pool |
| Co-immunoprecipitation | Protein-protein interactions | Identifying priming complexes |
| Phosphoproteomics | Phosphorylation changes | Mapping signaling pathways in priming |
| RNA-seq | Transcriptional changes | Assessing gene expression after perturbation |
| CRISPR screening | Gene essentiality for priming | Identifying novel priming regulators |
Live-Cell Imaging of DCV Priming
Total internal reflection fluorescence (TIRF) microscopy allows real-time visualization of DCV docking and priming at the plasma membrane. Fluorescently tagged DCV cargo (e.g., neuropeptide-Y-GFP) enables tracking of vesicle maturation and fusion competence. This method is ideal for assessing the effects of genetic perturbations on priming dynamics.
Reconstitution Assays for Exocytosis
In vitro reconstitution of calcium-mediated exocytosis of dense-core vesicles provides a reductionist system to study priming requirements. This assay uses purified DCVs and plasma membrane mimics to measure fusion in response to calcium. It has been used to identify essential proteins and lipids for priming.
Electrophysiology and Amperometry
Carbon-fiber amperometry measures catecholamine release from single DCVs, providing a readout of primed vesicle fusion. Patch-clamp capacitance measurements can quantify the readily releasable pool size, a proxy for priming. These techniques are used to evaluate priming defects in knockout or mutant cells.
Proteomics and Interaction Studies
Co-immunoprecipitation and mass spectrometry identify protein complexes involved in priming, such as CAPS1-rabconnectin3β. Phosphoproteomics can reveal signaling events that regulate priming. These methods help map the molecular network of DCV priming.
How CRISPR Can Be Used to Study GO:0061789 dense core granule priming
Knockout
CRISPR knockout of priming genes such as CAPS1, Munc13-2, or synaptotagmin-7 in neuroendocrine cell lines (e.g., PC12, INS-1) abolishes or reduces DCV priming, providing causal evidence for their roles. Knockout models are used to measure the primed vesicle pool via amperometry or TIRF.
Point Mutation
Point mutations in calcium-binding domains of synaptotagmin-7 or in CAPS1 can be introduced to dissect specific residues required for priming. These models help distinguish between docking and priming functions. Point-mutation knock-in cell lines are valuable for studying structure-function relationships.
Knock-in
Knock-in of tagged versions of CAPS1 or rabconnectin3β enables live-cell imaging and co-immunoprecipitation to study their interactions during priming. Knock-in of disease-associated variants can model human mutations affecting DCV priming. This approach preserves endogenous regulation.
Overexpression
Overexpression of tomosyn inhibits LDCV priming, while overexpression of CAPS1 or Munc13-2 enhances priming. Overexpression models are useful for gain-of-function studies and for testing whether a gene is sufficient to drive priming. They complement knockout approaches.
How EDITGENE Supports dense core granule priming Research
Researchers studying dense core granule priming-related genes often need to determine whether a candidate gene is causally involved in vesicle priming or merely correlated with secretion. EDITGENE provides CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as library screening and bioinformatics support, enabling rigorous functional dissection of GO:0061789.
Contact EDITGENE today to design your custom CRISPR model for dense core granule priming research.
Frequently Asked Questions About dense core granule priming
What is dense core granule priming?
Dense core granule priming (GO:0061789) is the process that converts unprimed dense core vesicles into fusion-competent vesicles capable of releasing their contents upon calcium signaling.
What genes are involved in dense core granule priming?
Key genes include CAPS1, Munc13-2, synaptotagmin-7, tomosyn, and rabconnectin3β/WDR7.
How is dense core granule priming regulated?
It is regulated by calcium, protein phosphorylation, and small GTPases, with positive regulators like CAPS1 and negative regulators like tomosyn.
What is the role of CAPS1 in DCV priming?
CAPS1 is a priming factor that regulates DCV acidification via rabconnectin3β/WDR7 and promotes exocytosis.
How does synaptotagmin-7 affect priming?
Synaptotagmin-7 acts as a calcium sensor that positions DCVs at the membrane and enables Munc13-2-dependent priming.
What is the function of tomosyn in priming?
Tomosyn inhibits LDCV priming in a calcium-dependent manner, acting as a negative regulator.
Which diseases are linked to defective DCV priming?
Neurological, psychiatric, and endocrine disorders have been linked to impaired DCV priming.
What methods are used to study dense core granule priming?
TIRF microscopy, amperometry, reconstitution assays, and proteomics are commonly used.
Can CRISPR be used to study DCV priming?
Yes, CRISPR knockout, knock-in, and point-mutation models are powerful tools for dissecting priming mechanisms.
What is the difference between docking and priming?
Docking is the initial attachment of DCVs to the plasma membrane, while priming converts docked vesicles into fusion-competent ones.
Conclusion
Dense core granule priming (GO:0061789) is a tightly regulated biological process essential for calcium-dependent secretion of hormones and neuropeptides. The interplay of CAPS1, Munc13-2, synaptotagmin-7, and tomosyn ensures that only appropriate numbers of DCVs become fusion-competent. Dysregulation of this process contributes to neurological and endocrine disorders, making it a key area for therapeutic research. CRISPR-based models, combined with advanced imaging and reconstitution assays, continue to unravel the molecular details of DCV priming. EDITGENE offers comprehensive services to support these investigations, from knockout and knock-in cell lines to library screening and bioinformatics.
References
- 1. Crummy E et al.. 2019. The priming factor CAPS1 regulates dense-core vesicle acidification by interacting with rabconnectin3β/WDR7 in neuroendocrine cells.. J Biol Chem 294(24):9402-9415 PMID: 31004036
- 2. Cocozza F et al.. 2023. Extracellular vesicles and co-isolated endogenous retroviruses from murine cancer cells differentially affect dendritic cells.. EMBO J 42(24):e113590 PMID: 38073509
- 3. Tawfik B et al.. 2021. Synaptotagmin-7 places dense-core vesicles at the cell membrane to promote Munc13-2- and Ca(2+)-dependent priming.. Elife 10 PMID: 33749593
- 4. Henry B et al.. 2024. A combination of four Toxoplasma gondii nuclear-targeted effectors protects against interferon gamma-driven human host cell death.. mBio 15(10):e0212424 PMID: 39292011
- 5. Yizhar O et al.. 2004. Tomosyn inhibits priming of large dense-core vesicles in a calcium-dependent manner.. Proc Natl Acad Sci U S A 101(8):2578-83 PMID: 14983051
- 6. Sugita S. 2008. Mechanisms of exocytosis.. Acta Physiol (Oxf) 192(2):185-93 PMID: 18005396
- 7. Miyake K et al.. 2016. CAPS1 RNA Editing Promotes Dense Core Vesicle Exocytosis.. Cell Rep 17(8):2004-2014 PMID: 27851964
- 8. Kreutzberger AJB et al.. 2017. Reconstitution of calcium-mediated exocytosis of dense-core vesicles.. Sci Adv 3(7):e1603208 PMID: 28776026
